^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
YK0901
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Yingkai Saiwei Biotech
Drug class:
TCR modulator, KRAS G12V inhibitor
Related drugs:
Phase 1
Peking University
Not yet recruiting
Last update posted :
07/06/2023
Initiation :
07/01/2023
Primary completion :
07/01/2024
Completion :
07/01/2026
KRAS
|
KRAS G12V • KRAS G12
|
cyclophosphamide • oxaliplatin • YK0901
Share
